Liu, Tianci
Liu, Na
Wang, Yizhao
Li, Tao
Zhang, Man
Funding for this research was provided by:
Validation and application development of a new urine diagnostic and monitoring marker test in type II diabetes-related diseases (Z211100002921040)
Article History
Received: 30 March 2023
Accepted: 13 June 2023
First Online: 22 June 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Peking University Ninth School of Clinical Medicine(sjtkyll-lx-2022(134)). Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare that they have no competing interests in this section.